GeneSeek Becomes Illumina's First Certified Service Provider to Use Infinium DNA Analysis BeadChips for Agriculture Research
News Jul 29, 2008
Illumina, Inc. has announced that GeneSeek Inc. is the first organization focusing on this key research community to become an Illumina CSPro® (certified service provider). Illumina CSPro is a collaborative service provider partnership dedicated to ensuring delivery of the quality data available for genetic analysis applications.
Using Illumina's Infinium® products, including the iSelect™ BovineSNP50, CanineSNP20, and EquineSNP50 BeadChips, GeneSeek offers its customers access to large-scale interrogation of plant and animal genomes.
"Interest in the Illumina CSPro program continues to grow with more than 20 academic and commercial technology providers already certified or in the process of certification. With GeneSeek as a partner, we are making it easier for the agricultural community to access high-quality genetic analysis solutions for their research," said Karen Possemato, Director of Corporate Marketing at Illumina.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE